Literature DB >> 7789533

Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin.

D A Weidner1, B C Valdez, D Henning, S Greenberg, H Busch.   

Abstract

To design optimal strategies for intracellular delivery of antisense phosphorothioate oligonucleotides, it may be useful to understand their interaction with cellular macromolecules. Nuclear extracts from LOX amelanotic myeloma cells were studied for protein binding to phosphorothioate oligonucleotides using a Southwestern protocol. Multiple nuclear proteins bound to the phosphorothioate oligonucleotides but no detectable protein binding was found to phosphodiester oligonucleotides. The protein with the strongest binding signals was shown by immunoprecipitation to be nucleolar C23/nucleolin, a 110 kDa protein. With glutathione S-transferase/nucleolin fusion protein constructs, the region of nucleolin containing the RNA recognition motifs had binding activity to phosphorothioate oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789533     DOI: 10.1016/0014-5793(95)00517-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.

Authors:  P Lorenz; B F Baker; C F Bennett; D L Spector
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

Review 3.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

4.  The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules.

Authors:  Wenzhan Yang; Prajakta Gadgil; Venkata R Krishnamurthy; Margaret Landis; Pankajini Mallick; Dipal Patel; Phenil J Patel; Darren L Reid; Manuel Sanchez-Felix
Journal:  AAPS J       Date:  2020-01-03       Impact factor: 4.009

5.  Effects of oligonucleotide length and atomic composition on stimulation of the ATPase activity of translation initiation factor elF4A.

Authors:  M L Peck; D Herschlag
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

Review 6.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

7.  Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.

Authors:  G Hartmann; A Krug; K Waller-Fontaine; S Endres
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.

Authors:  Byong Hoon Yoo; Elena Bochkareva; Alexey Bochkarev; Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2004-04-02       Impact factor: 16.971

10.  TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.

Authors:  Xue-hai Liang; Wen Shen; Hong Sun; Thazha P Prakash; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2014-05-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.